Postpartum Care Support for Gestational Diabetes and Hypertension

Not currently recruiting at 1 trial location
SB
GW
CU
Overseen ByChristina Urbina, MBA
Age: 18+
Sex: Female
Trial Phase: Phase 3
Sponsor: Northwestern University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to assist new mothers who experienced gestational diabetes or high blood pressure during pregnancy. It seeks to connect these women to primary care for ongoing health checks after childbirth. Participants will receive education, support, and regular check-ins to ensure optimal care. Women who have recently given birth, had gestational diabetes or pregnancy-related high blood pressure, and attended prenatal care in the last six months may be suitable candidates. The trial compares usual care with a new support program, which includes OB Provider Clinical Decision Support (CDS) and other interventions, to determine which is more effective. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to potentially groundbreaking healthcare advancements.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that Clinical Decision Support Systems (CDSS) in maternity care are increasingly common and can enhance safety and outcomes. These systems assist healthcare providers in making better decisions. Although specific safety data for postpartum care support treatments like OB Provider Clinical Decision Support and Primary Care Provider Clinical Decision Support are not detailed, the widespread use of CDSS indicates its acceptance in healthcare settings.

Text messaging interventions have demonstrated positive results in managing conditions like gestational diabetes. Studies suggest that these mobile health tools can improve pregnancy outcomes and aid in lifestyle changes.

Patient education, whether in an OB or primary care setting, is generally considered safe and aims to inform and support patients in managing their health.

Patient outreach, which involves contacting patients to keep them engaged in their care, is also a well-regarded approach for improving health outcomes.

Overall, these components of the STEP-UP trial rely on methods commonly used and well-tolerated in healthcare.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a comprehensive approach to postpartum care, addressing both gestational diabetes and hypertension with a combination of clinical decision support, patient education, and digital outreach. Unlike standard care, which typically involves routine check-ups and medication management, this new approach integrates seamless communication through text messaging and proactive outreach to ensure continuous care and monitoring. By promoting linkage to primary care and ongoing evaluation, this method aims to improve long-term health outcomes for postpartum women, potentially offering a more personalized and efficient care experience.

What evidence suggests that this trial's treatments could be effective for postpartum care support?

Research has shown that many women who experienced gestational diabetes (GDM) or high blood pressure during pregnancy (HDP) often do not continue with specialized care after giving birth. For instance, only about one in three women with GDM and half of those with HDP see a primary care doctor within six months postpartum. The STEP-UP program in this trial aims to change this by helping these women connect with primary care and supporting regular health check-ups. Studies suggest that programs like STEP-UP can improve follow-up care and may lower long-term health risks. Although more research is needed for firm conclusions, early results are promising in closing the gaps in postpartum care.16789

Who Is on the Research Team?

SB

Stacy Bailey, PhD MPH

Principal Investigator

Northwestern University

Are You a Good Fit for This Trial?

The STEP-UP trial is for postpartum women over 18 who had gestational diabetes or hypertension during pregnancy. Participants must have attended a prenatal care visit at a study site within the last 6 months and speak English or Spanish.

Inclusion Criteria

Attended at least 1 prenatal care visit at a study site in the 6 months prior to delivery
Delivered during an accrual period
You were diagnosed with gestational diabetes or high blood pressure during your previous pregnancy.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

STEP-UP intervention promoting linkage to primary care and ongoing chronic disease evaluation for postpartum women with prior GDM and/or HDP

6 months
Regular OB and primary care visits

Follow-up

Participants are monitored for completion of primary care visits and dysglycemia testing

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • OB Provider Clinical Decision Support (CDS)
  • Patient Education (OB Visit)
  • Patient Education (Primary Care Visit)
  • Patient Outreach
  • Primary Care Provider Clinical Decision Support (CDS)
  • Text messaging
Trial Overview This trial tests if patient education, text messaging, outreach, and clinical decision support can help these women transition to primary care for chronic disease management after giving birth.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Usual CareActive Control1 Intervention
Group II: STEP-UPActive Control6 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials
1,674
Recruited
989,000+

AllianceChicago

Collaborator

Trials
8
Recruited
18,700+

Cook County Health

Collaborator

Trials
47
Recruited
16,800+

Published Research Related to This Trial

An educational intervention provided by a nurse educator significantly increased postpartum diabetes testing rates for women with gestational diabetes mellitus (GDM) from 33% to 53% between two cohorts studied from 2002 to 2009.
The increase in postpartum testing was observed across various racial and ethnic groups, with notable improvements in whites, Latinas, and Asians, highlighting the effectiveness of educational counseling in promoting follow-up care.
Patient counseling increases postpartum follow-up in women with gestational diabetes mellitus.Stasenko, M., Liddell, J., Cheng, YW., et al.[2021]
Patient safety in obstetric care is crucial, as it directly impacts health care quality and is influenced by various factors, particularly communication, which is a key contributor to adverse events.
While most women give birth without significant safety incidents, a concerning minority still experience events that could negatively affect their outcomes, highlighting the need for improved safety measures in obstetric practices.
Obstetric patient safety: an overview.Grobman, WA.[2012]
The model curriculum for perinatal education effectively bridged the gap between prenatal care and postpartum support for high-risk inner-city women, enhancing their overall health knowledge.
The interdisciplinary approach not only increased clients' knowledge but also promoted positive behavioral changes, highlighting the importance of comprehensive perinatal education in improving health outcomes.
Patient education: bridging the gap between inpatient and ambulatory care.Evans, V., Foley, M., Pagan, L., et al.[2007]

Citations

The STEP-UPYet studies show only one third of women with GDM and about half of women with HDP see a primary care provider within 6 months postpartum. Of those with GDM, ...
Supporting Transitions to Primary Care Among Under ...STEP-UP will promote linkage to primary care and ongoing chronic disease evaluation for postpartum women with prior gestational diabetes mellitus (GDM) ...
Postpartum Care Support for Gestational Diabetes and ...STEP-UP will promote linkage to primary care and ongoing chronic disease evaluation for postpartum women with prior gestational diabetes mellitus (GDM) and/or ...
randomised, single centred, blinded, controlled trialResults 84 (80%) of 105 women in the intervention and 95 (90%) of 106 in the usual care completed the study. There was not enough evidence of a ...
Opportunities in the Postpartum Period to Reduce ...One of the largest trials tested the comparative effectiveness of a health system–based, DPP-derived intervention on 12-month postpartum weight ...
Clinical decision support systems for maternity careThe use of Clinical Decision Support Systems (CDSS) is increasing throughout healthcare and may be able to improve safety and outcomes in maternity care.
Implementation of a novel surveillance and clinical ...We analyzed the demographic data and outcomes for all patients in the CDS and pre-CDS groups (total population) and also for the subgroup of patients with pre- ...
Project Details - NIH RePORTERYet studies show only one third of women with GDM and about half of women with HDP see a primary care provider within 6 months postpartum. Of those with GDM, ...
Hypertension in Pregnancy and PostpartumHBPM increases postpartum BP ascertainment (92% versus 44%), improves postpartum visit attendance (adjusted OR, 2.30 [95% CI, 1.05–5.07]), ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security